Company Profile
Sumitomo Pharma Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic.
Additionally, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Incorporated in 1897 and headquartered in Osaka, Japan, the company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. before rebranding in April 2022. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.